[The PATENT-1 and CHEST-1 studies]

G Ital Cardiol (Rome). 2015 Feb;16(2):59-64. doi: 10.1714/1798.19570.
[Article in Italian]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Clinical Trials, Phase III as Topic
  • Disease Progression
  • Dyspnea / etiology
  • Dyspnea / prevention & control
  • Endpoint Determination
  • Exercise Test
  • Guanylate Cyclase / metabolism
  • Humans
  • Hypertension, Pulmonary / blood
  • Hypertension, Pulmonary / classification
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / drug therapy*
  • Natriuretic Peptide, Brain / blood
  • Peptide Fragments / blood
  • Pyrazoles / administration & dosage
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use*
  • Pyrimidines / administration & dosage
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Vascular Resistance / drug effects
  • Walking
  • World Health Organization

Substances

  • Peptide Fragments
  • Pyrazoles
  • Pyrimidines
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • Guanylate Cyclase
  • riociguat